|
Market Closed -
Nasdaq
23:00:00 14/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 51.44 USD | -5.11% |
|
-11.45% | -34.98% |
| 09-10 | Ionis Pharmaceuticals, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-10-2026 08:45 AM | |
| 09-09 | BofA Adjusts Price Target on Ionis Pharmaceuticals to $91 From $93 | MT |
| Market Cap | 8.55B 7.4B 6.99B 6.33B 11.88B 817B 11.98B 83.36B 32.09B 416B 32.1B 31.4B 1,319B | P/E 2026 * |
-14.2x | P/E 2027 * | -27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 8.45B 7.31B 6.9B 6.26B 11.74B 807B 11.83B 82.36B 31.7B 411B 31.72B 31.02B 1,304B | EV / Sales 2026 * |
9.25x | EV / Sales 2027 * | 6.23x |
| Free-Float |
99.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IONS | Delayed | |
CBOE
| IONS | Real-time | |
|
Tradegate
| ISI | Real-time | |
|
London S.E.
| 0JDI | Delayed | |
|
Borsa Italiana
| 1IONS | End-of-day quote | |
|
Boerse Muenchen
| ISI | Real-time | |
|
Mexican S.E.
| IONS * | End-of-day quote | |
|
Deutsche Boerse AG
| ISI | Delayed | |
|
Börse Stuttgart
| ISI | Delayed | |
|
Xetra
| ISI | Delayed |
Last Transcript: Ionis Pharmaceuticals, Inc.
| 1 day | -5.11% | ||
| 1 week | -11.45% | ||
| Current month | -14.78% | ||
| 1 month | -7.93% | ||
| 3 months | -29.80% | ||
| 6 months | -27.74% | ||
| Current year | -34.98% |
| 1 week | 51.31 |  | 57.43 |
| 1 month | 51.31 | | 64.19 |
| Current year | 50 | | 86.74 |
| 1 year | 50 | | 86.74 |
| 3 years | 23.95 | | 86.74 |
| 5 years | 23.95 | | 86.74 |
| 10 years | 23.95 | | 86.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
D. Walke
IRC | Investor Relations Contact | 60 | 01/07/2012 |
Brett Monia
CEO | Chief Executive Officer | 64 | 01/01/2020 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 64 | 01/05/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Klein
BRD | Director/Board Member | 64 | 13/12/2005 |
| Director/Board Member | 73 | 01/05/2002 | |
Brett Monia
BRD | Director/Board Member | 64 | 25/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/31/26 A | Others | Chief Technology Officer | 110 | 0.0001% | ||
| 8/31/26 A | Others | Executive/Senior Manager | 58 | 0.0000% | ||
| 8/31/26 A | Others | Founder | 98 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.11% | -11.45% | -18.56% | +19.21% | 9.01B | |
| +0.56% | -5.82% | -2.45% | +9.99% | 45.48B | |
| +0.66% | -2.34% | +340.62% | +524.38% | 43.68B | |
| +1.49% | -0.78% | +41.90% | +22.65% | 43.09B | |
| +2.11% | -1.24% | +9.09% | +76.85% | 39.4B | |
| +0.34% | -4.94% | +9.34% | +40.23% | 31.91B | |
| +0.53% | -2.08% | - | - | 17.31B | |
| +1.34% | +0.70% | +21.35% | +111.39% | 16.4B | |
| +2.07% | -0.77% | +13.07% | +32.89% | 14.24B | |
| -1.85% | -5.33% | +78.63% | +34.13% | 13.28B | |
| Average | +0.21% | -3.34% | +54.78% | +96.86% | 27.38B | |
| Weighted average by Cap. | +0.74% | -3.37% | +72.68% | +123.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 913M 790M 746M 676M 1.27B 87.2B 1.28B 8.9B 3.43B 44.38B 3.43B 3.35B 141B | 1.38B 1.2B 1.13B 1.02B 1.92B 132B 1.94B 13.48B 5.19B 67.21B 5.19B 5.08B 213B |
| Net income | -584M -505M -477M -432M -811M -55.77B -818M -5.69B -2.19B -28.38B -2.19B -2.14B -90.1B | -314M -272M -257M -233M -437M -30.04B -440M -3.07B -1.18B -15.29B -1.18B -1.15B -48.52B |
| Net Debt | -103M -89.17M -84.16M -76.28M -143M -9.84B -144M -1B -387M -5.01B -387M -378M -15.9B | 68.31M 59.14M 55.82M 50.59M 94.93M 6.53B 95.69M 666M 256M 3.32B 257M 251M 10.54B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/09/26 | $51.44 | -5.11% | 5,767,494 |
| 11/09/26 | $54.21 | -2.59% | 2,175,778 |
| 10/09/26 | $55.65 | -0.66% | 3,057,309 |
| 09/09/26 | $56.02 | -1.22% | 3,037,757 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IONS Stock
Select your edition
All financial news and data tailored to specific country editions
